Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Inogen (INGN - Research Report) on November 4 and set a price target of $24.00. The company's shares closed yesterday at $20.86.Blackman covers the Healthcare sector, focusing on stocks such as Dexcom, Insulet, and Alphatec Holdings. According to TipRanks, Blackman has an average return of 16.6% and a 49.23% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Inogen with a $29.00 average price target, representing a 39.02% upside. In a report released on November 3, J.P. Morgan also maintained a Hold rating on the stock with a $22.
https://www.tipranks.com/news/blurbs/inogen-ingn-receives-a-hold-from-stifel-nicolaus?utm_source=advfn.com&utm_medium=referral